个股论点
围绕单一股票的投资逻辑与仓位表态 · 共 2208 条 · 第 14 / 45 页
-
分析指出SK海力士和三星利润未受能源价格实质影响，市场情绪短期主导。
@jayjay12246 是的，我已经完成了分析，发现SK海力士(SK Hynix)和三星(Samsung)的营业利润并未受到石油、液化天然气(LNG)和氦气(Helium)的实质性影响。尽管表面看起来很吓人。人们短期内交易的是情绪。如果你的名字不是$HIMS，整体情绪看起来相当糟糕。
英文原文
@jayjay12246 Yeah, I’ve already done the analysis and found SK Hynix/Samsung operating income wasn’t very materially affected by Oil, LNG, and helium. Even though it looks very scary. People trade off sentiment short term. And sentiment looks pretty bad in general if your name is not $HIMS.
-
指出HIMS积压订单激增，但对其后续走势持观望态度。
@frsinvesting 是的，我已经看到 $HIMS 积压了数百万美元的订单。不过我不确定这最终会如何演变，只是对当前局势进行评论。 https://t.co/oPFAX4mLNf
英文原文
@frsinvesting Yeah I’m already seeing millions in backlogged orders for $HIMS. Idk how it plus out though, just commentating in the situation. https://t.co/oPFAX4mLNf
-
为被做空重创的$HIMS投资者加油，并讽刺做空者。
@moninvestor 如果 $HIMS 发生那样的情况会很有趣。 我个人只是在为过去几个月被做空者重创的 $HIMS 投资者加油。 希望他们至少能从试图让美国公司破产的尝试中吸取一些教训。
英文原文
@moninvestor Would be interesting if that happened for $HIMS. I’m personally just cheering on the $HIMS investors that were beat up by short sellers over the past few months. Hopefully they at least learn some lessons trying to bankrupt American companies.
-
$HIMS因与$NVO合作及基本面反转，周一或现逼空行情。
$HIMS 隔夜交易即将开始，周五收盘价为 $22。 此前该股交易价为 $70，但鉴于： - $NVO / 美国政府诉讼威胁使公司破产 - $HIMS 来自 GLP-1 的收入减速。 空头做空了该公司 40% 以上的流通盘。 所有这一切在周五盘后发生了逆转，据彭博社报道，$NVO 与 $HIMS 达成合作，这是一个极其令人惊讶的事件。 由于收入重新加速、为全球扩张进行的新收购、资产负债表无破产威胁，以及现在与 $NVO 的合作： 空头现在面临无限亏损，做空了接近一半的流通盘。 目前的格局看起来非常适合发生逼空(short squeeze)。 然而，结果主要取决于散户的反应，或者他们是否会向空头投降。 无论如何，每个人都会关注周一，看看 $HIMS 的仙人掌药丸(cactus pills)是否能作为对抗原油的宏观经济避险资产。
英文原文
$HIMS overnight trading will begin soon after finishing Friday at $22. Previously it traded at $70, but given: - $NVO / US Gov lawsuit threatening to bankrupt the company - $HIMS revenue deceleration from GLP-1. Short sellers shorted 40%+ of the company’s float. All of that flipped Friday after hours once $NVO partnered up with $HIMS per Bloomberg, in an extremely surprising event. Due to revenue reaccelerating, new acquisitions for global expansion, no threats of balance sheet insolvency, and now a partnership with $NVO: Short sellers now face infinite losses, selling close to half of the float short. And the setup looks prime for a short squeeze. However, the outcome primarily depends on how retail reacts or if they capitulate to short sellers. Either way, everyone will be watching Monday to see whether $HIMS cactus pills serves as a macroeconomic flight to safety against crude oil.
-
指出IREN风险披露被无视，暗示市场处于非理性阶段。
@CK_Cryptoklepto 我们可能正处于这个阶段，因为我指出 $IREN 的风险披露(risk disclosures)就被称为机器人(bot)了，哈哈 https://t.co/DTM73USeMx
英文原文
@CK_Cryptoklepto We’re probably at this stage since I’m getting called a bot for pointing out $IREN risk disclosures lol https://t.co/DTM73USeMx
-
BKKT等公司利用热点炒作后通过ATM减持，散户受损严重。
纵观 $BKKT、$ASST 以及可能的 $IREN，其策略如出一辙。围绕热门叙事（比特币库藏、AI 智能体、数据中心）制造巨大的散户炒作热度，等待股价飙升，随后立即通过定向增发(ATM)抛售股份以资助运营并支付高管基于股票的薪酬(SBC)。公司本身没问题，但个体散户股东受到的伤害最大。
英文原文
Across $BKKT, $ASST, and maybe $IREN. The strategy has been identical. Generate massive retail hype around a hot narrative (Bitcoin treasuries, AI agents, DCs), wait for the stock to spike, and immediately dump shares via ATMs to fund operations and pay executive SBCs. The companies themselves are fine but the individual retail shareholder is left hurt the most.
-
呼吁理性看待 $IREN 风险及 ATM 融资争议
没错。很高兴大家能看清全貌，从而就 $IREN 的风险做出明智决策。不幸的是，为了证明 60 亿美元 ATM（自动取款机融资）的合理性，出现了大量人身攻击。但我认为任何理性的投资者都能从噪音中辨别出大方向的正确性。
英文原文
Exactly. It’s good people have the full picture so people can make informed decisions from risks with $IREN. Unfortunately there’s been a lot of personal attacks to explain why the $6B ATM is justified. But I think any rational investor can discern what’s directionally right from the noise.
-
反驳对IREN和BKKT风险的忽视，指出巨额烧钱和管理层关联。
@JC_GetRichSlow 当存在60亿美元的重大现金消耗(ATM)时，这并没有为讨论增添任何价值。 此外，$IREN 管理层还参与了 $BKKT 等公司，这也是公开信息。 将明显的风险和历史记录斥为“散布恐慌”是无关紧要的。 https://t.co/QifmHkAkfR
英文原文
@JC_GetRichSlow It’s not adding nothing to the dialogue when there’s a material $6 Billion USD ATM. It’s also public information $IREN management was involved companies $BKKT as well. Dismissing clear risks and track records as “fearmongering” is immaterial. https://t.co/QifmHkAkfR
-
指出IREN管理层过往记录公开，质疑信任其处理稀释的论点。
尽管你可以随意发表看法，但这无法改变事实。关于 $IREN 管理层在 $BKKT 和 $ASST 上的过往记录，所有信息都是公开的。如果某人的核心论点是“信任管理层能处理好稀释问题”，那么了解这一点确实至关重要。
英文原文
Feel free to say whatever you want, but it doesn’t change the reality of things. It’s all public information with $IREN management track record with $BKKT and $ASST. It’s definitely important to know if someone is making the primary argument of trusting in management to handle dilution
-
警告 IREN 60 亿 ATM 稀释将重创散户，勿盲目信任管理层。
支持 Iren 进行 60 亿美元稀释的主要论点是： “信任 $IREN 管理层对稀释的管理能力。” 如果你查看 IREN 管理层在 $BKKT 和 $ASST 上的实际历史： 这两家公司都通过自动做市商(ATM)发行彻底摧毁了股东价值。 导致所有原始散户股份价值下跌 98-99%。 像 Bakkt 这样的公司表现尚可。 但高管的股票薪酬 + 稀释抹去了散户的所有股权价值。 如果一家公司申请 60 亿美元的 ATM 稀释，你应该预期他们会使用它并据此调整仓位。 也许 $IREN 的结果会不同。 但一边说“信任管理层”，一边看这些炒作型散户股票的管理层记录 -> ATM 稀释抹去所有价值的情况已多次发生。 公司最终可能没事，别把这和你的股票表现混为一谈。 我最关心散户股东胜过公司高管，这就是我分享关于 $IREN 60 亿 ATM 的红旗信号的原因。
英文原文
The primary argument for Iren’s $6B dilution was: “Trust in $IREN management with managing dilution.” If you look at the actual history of IREN management with: $BKKT and $ASST. Both companies have completely obliterated shareholder value from ATM dilution. Dropping all original retail share value down by 98-99%. Companies like Bakkt have been doing okay. But both stock based compensation to executives + dilution wiped out all equity value from retail. If a company files for $6 Billion in ATM dilution, you should expect them to use it and position accordingly. Maybe $IREN turns out differently. But saying “Trust in Management” then looking at the track record of management of hype retail stocks -> ATM dilution wiping out all value has happened multiple times. The company will likely end up fine don’t conflate that with the performance of your shares. I care the most about retail shareholders over corporate executives, which is why I’m sharing the red flag about $IREN $6B ATM.
-
澄清对IREN的分析仅为风险提示，非买卖建议。
@Peregrino1708 是的，同意。我并没有告诉人们要卖出或买入 $IREN，只是列出风险和最可能的结果。最终人们可以自由做出自己的选择。但拥有基于实质而非其他持有者带来的无关噪音的理性推理是很好的。
英文原文
@Peregrino1708 Yep, agreed. I’m not telling people to sell or buy $IREN, just laying out the risks and most likely outcomes. In the end people are free to make their own choices. But it’s good to have grounded reasoning outside of immaterial noise from other holders.
-
指出EWY因穿透结构高度集中于SK海力士和三星。
并非如此，$EWY 主要由 SK 海力士(SK Hynix)和三星(Samsung)构成，这得益于像 SK Square（90% 净资产价值 NAV 来自 SK 海力士）或三星电子的其他投票权结构股份等穿透式结构。 或者是其他三星旗下公司，其净资产价值由持有三星电子股份构成。 它的集中度比绝大多数人意识到的要高得多。
英文原文
Not really, $EWY is majority SK Hynix/Samsung due to pass through structures like SK Square (90% NAV Sk Hynix) or Samsung Electronic’s other voting structure shares. Or other Samsung companies NAV made up of holding Samsung Electronics shares. It’s a lot more concentrated than the vast majority of people realize.
-
建议等待 $IREN 稀释周期结束且散户提供流动性后再做多。
是的，这是完美的总结。人们将 $IREN 业务表现良好（我认为作为一家与 $MSFT 合作的 DC 它也会如此）与其股价表现良好混为一谈。等待现有散户/逢低买入者为 60 亿美元的稀释周期提供流动性，待其结束后再建立多头头寸，是高度理性的。
英文原文
Yes this is the perfect summary. People conflate $IREN doing well (which I think it will too as a DC with $MSFT partnership), with their share prices doing well. Waiting for existing retail/dip buyers to serve as liquidity for the $6 billion dilution cycle finishes before going long is a highly rational.
-
IREN公司虽能成功，但60亿稀释压力将压制股价。
@mattpurdy89 谢谢，我的观点非常微妙。我认为 $IREN 作为一家公司会取得成功。但这并不意味着你的股价也会上涨。这仅仅是由于 $60 亿不可避免的稀释和抛售压力这一结构性现实所致。
英文原文
@mattpurdy89 Thanks, my thought is very nuanced. I think $IREN as a company will succeed. But that doesn't mean your share prices will too. That's just due to the structural realities of $6B in inevitable dilution and selling pressure.
-
批评针对IREN融资的人身攻击，强调应关注实质并维护散户利益。
不幸的是，人们陷入各种人身攻击，而不是讨论 $IREN $60 亿 ATM（自动取款机融资）的实际内容和影响。这只是诚实的现实，情绪很多时候会蒙蔽判断，尤其是当你持有该股票时。无论如何，我将始终优先考虑散户投资者的利益，即使人们想继续人身攻击来为 $60 亿 ATM 辩护。
英文原文
Unfortunately people go into all sorts of character attacks instead of discussing the actual substance and implications $IREN's $6B ATM. This is just the honest reality of things, emotions cloud judgement a lot of times, especially if you hold the stock. Regardless, I'll always look out for retail interest above anyone else, even if people want to continue personal attacks to justify a $6B ATM.
-
IREN稀释60亿损害散户利益，建议等待现有股东提供流动性。
是的，$IREN 这家公司在稀释 $60 亿并在公开市场抛售之后，前景可能会不错。然而，这是以牺牲当前散户股东和“逢低买入者”的利益为代价的。如果你关心股票价值的上涨，更明智的选择是等待现有持有者提供流动性。
英文原文
Yep, $IREN as a company will likely do well once they dilute $6B and sell that into the open market. However, this is at the expense of retail equity holders now and "dip buyers". The smarter alternative if you care for your value in the stock to go up is to wait until existing holders serve as liquidity.
-
警告散户勿在IREN ATM融资前抄底，建议等待稀释完成后再做多。
如果你读过我的披露声明，我对 $IREN 没有任何经济利益或持仓。 我只是陈述一个残酷的现实：散户“逢低买入者”不可避免地会被稀释，并成为 $IREN 60亿美元自动取款机(ATM)融资的流动性来源。 如果你想做多 $IREN 并从股权增值中获利，让其他人先承担稀释冲击，然后再入场做多，可能是更明智的选择。 尤其是因为自动取款机(ATM)融资是更具散户破坏性的融资方式之一。
英文原文
If you read my disclosure, I have zero economic interest or positions in $IREN. I'm just stating the harsh reality that retail "dip buyers" will be inevitably be diluted and serve as liquidity for the $6 Billion ATM. Letting others take the dilution hit first and going long after is likely the smarter alternative if you want to long $IREN and benefit from equity appreciation. Especially since ATMs are one of the more retail-destructive methods to finance.
-
作者指出IREN巨额定向增发将压制股价，反驳逢低买入观点。
我在此是为了保护散户利益。我对 $IREN 没有任何经济利益。正如你所说，随波逐流确实容易得多。但残酷的现实是，60亿美元的定向增发(ATM)规模巨大，将成为持有者的结构性压制因素。当一半的市场份额不可避免地通过增发并针对散户抛售时，我无法理解任何人如何能诚实地称其为“逢低买入机会”。
英文原文
I'm here to protect retail interests. I have zero economic interest in $IREN. As you mentioned, it's a lot easier to go with the flow. But the harsh reality is $6B ATM is enormous and will serve as a structural overhang for holders. I can't see how anyone could honestly say it's a "dip buying opportunity" when half of the marketcap is inevitably minted then sold against retail holders.
-
IREN巨额ATM增发将严重稀释散户，建议等待稀释完成后再做多。
$IREN 60亿美元的自动取款机(ATM)增发额度非常庞大。 对于持有 $IREN 的人来说，你可能不想听到这个真相： -> 等待现有持有者被稀释到 oblivion（虚无） -> 利用他们为你“抄底”这60亿美元的新股。 -> 然后做多。 如果你现在做多： 那不可避免的60亿美元新股 + 卖压，从结构上限制了你的股权上行空间，并在任何反弹中构成压制。 公司申请60亿美元的ATM额度不是为了不用。 他们会用，并且在任何反弹中尽可能多地使用。 现实是，虽然有其他融资方式，但ATM对散户股东最具破坏性。 $IREN 本身是一家像样的公司，不像电影院股票，但正如提到的过度稀释： 你可能会看到 $IREN 的市值回升至200亿美元左右，但你的股价价值却暴跌。 简而言之：残酷的现实是 $IREN 可能在根本上成功并建立庞大的数据中心(DC)布局。 但这代价是严重稀释散户股东。散户投资者应更关心自己股票价值的增加，而非公司整体价值。 披露：我在该公司没有任何经济利益或持仓，但我确实关心优先考虑散户利益。
英文原文
$IREN $6 Billion ATM is massive. For the people who hold $IREN, the truth you might not want to hear is: -> Wait until existing holders get diluted to oblivion -> Use them to "buy the dip" of $6 Billion in new shares for you. -> Go long after. If you're long now: That inevitable $6B in new shares + selling pressure structurally caps upside in your equity and serves as a overhang in any rally. Companies don’t file a $6B ATM not to use it. They will, and as much as they can on any rally. The reality is that there are other financing methods, but ATMs are the most destructive ones to retail shareholders. $IREN itself is a solid company unlike movie theater stocks, but like excessive dilution referenced: You will likely see the marketcap of $IREN go up back toward $20B, but the your share prices tanking in value. TLDR: The harsh reality is $IREN might fundamentally succeed and build a massive DC footprint. But it's at the cost of heavily diluting retail shareholders. Retail investors should care more about the value of their own stock increasing over the company's value. Disclosure: I have zero economic interest or positions in the company, but I do care about prioritizing retail interest.
-
AI使内存需求结构化，SK海力士即便在基准情景下仍被低估。
由于人工智能(AI)，内存需求是结构性的。但价格上涨可能并非如此。 当摩根士丹利(Morgan Stanley)预测： ~1329亿美元（2026年）+ ~1670亿美元（2027年）= 未来两年SK海力士(SK Hynix)的营业利润约为3000亿美元，而SK海力士的市值约为4000亿美元。 他们将坐拥大量现金。我甚至没有引用麦格理(Macquarie)预测5000亿美元营业利润的牛市情景，因为那看起来太荒谬了。 但在基准情景下，如果DRAM/NAND价格下跌，创纪录的营业利润回归到早期水平。 由于AI需求使内存需求具有结构性，它看起来仍然被低估。 AI从根本上改变了像GPU或内存这样被标记为“大宗商品”的运作方式。 这不再是2022年智能手机/消费电子需求下降导致价格崩盘，你可以简单地引用低市盈率(P/E)做空像以前那样的大宗商品周期。
英文原文
Memory demand is structural due to AI. Price hikes might not be. When there's Morgan Stanley projections of: ~$132.9B (2026) + ~$167.0B (2027) = ~300B operating profit from SK Hynix in the next two years and SK Hynix's marketcap is ~$400B. They will be sitting on piles of cash. I'm not even citing bull-case projections where Macquarie projects $500B operating income because it looks absurd. But in the base case event that record operating income goes back to earlier levels if dram/nand prices decrease. It still looks undervalued as AI demand makes memory structural. AI fundamentally changes how labelled "commodities" work like GPUs or memory. This is not 2022 where smartphone/consumer electronic decreases crash prices and you can just cite low/pe = short like commodity cycles before.
-
LNG担忧被夸大，成本可转嫁，看好韩国半导体股反弹。
关于液化天然气(LNG)/JKM的担忧讨论很多，看起来仍然被夸大了，即使问题不只是氦气。如果霍尔木兹海峡关闭，韩国大部分LNG进口将基本不受影响，因为它们通过澳大利亚、美国、马来西亚、印度尼西亚等不经过霍尔木兹的路线到达。例如，2024年82%的进口是长期合同而非现货，但可能挂钩油价，我同意你关注油价影响。然而，即使成本飙升，运营支出(operex)也会通过涨价转嫁给超大规模云服务商(hyperscalers)，而不是压缩利润率。这就是为什么我认为韩国股票现在仍然是极具吸引力的多头标的，因为SK海力士(SK Hynix)市值跌至3000亿美元以上，而三星在第二季度再次将NAND闪存价格翻倍，以推动营业利润超过预期。
英文原文
Lot of discussion around LNG/JKM fears still look overblown, even if it's not just helium. Majority of SK’s LNG imports would be largely unaffected if Hormuz were closed as they arrive via Hormuz-free routes like Australia, US, Malaysia, Indonesia. Then 82% of 2024 imports for example were long term contracts, not spot, but likely oil indexed and I'd agree with you there on looking at oil impact. However, even if costs shot up, opex would be passed onto hyperscalers through price hikes rather than see margins being compressed. Which is why I see KR equities still be a compelling long around now, as Sk Hynix drops to high $300B+ MC and Samsung doubles nand prices again in q2 to boost operating income past projections
-
SK海力士否认受氦气中断影响，市场误杀提供交易机会。
任何供应链中断都是逆风，计入风险溢价是合理的。但如果 SK 海力士 ($SKHYNIX) 明确表示氦气（Helium）中断对其零影响，而其他分析师/市场却因氦气担忧抛售 SK 海力士，这看起来就是一个利用市场过度反应获利的机会。
英文原文
Any sort of supply chain disruption is a headwind and it makes sense to price in risk-levels. But if SK Hynix goes out and says there’s zero affect on them from Helium disruption. Then other analysts/markets say sell off SK Hynix off Helium concerns, then looks like an opportunity to capitalize off an overreaction.
-
分析AAOI估值与基本面，建议结合营收和供应链地位而非仅看图表。
如果 $AAOI 股价上涨 100%，并声称明年每月营收将达 3.78 亿美元，这得益于 $META、$MSFT 和 $AMZN 购买其能生产的所有供应品。而它现在的估值为 70 亿美元。我不会只看图表，还会关注营收预测、毛利率、在供应链中的地位以及预测数据。
英文原文
If $AAOI ran up 100% and stated they're doing $378M/month revenue next year off likely $META, $MSFT, and $AMZN buying any supply they can make. And they're valued at $7B now. I wouldn't look at the chart alone, would look at revenue projections, gross margins, position in supply chains, and forecasts.
-
POET 依赖 MRVL 产品，非瓶颈而是高潜力架构赋能者。
前几天我写了一篇关于 $POET 的小文章。他们目前很大程度上依赖 $MRVL 的 Celestial 产品。根据 Marvell 的财报，Celestial AI 的收入预测为 2028 年 5 亿美元，2029 年 10 亿美元（POET 在 Starlight 的物料清单 BOM 中占比可能约为 10%）。我不认为 $POET 是瓶颈环节，而是一个具有高潜力的架构赋能者。
英文原文
I did a small writeup on $POET the other day. They're largely dependent on $MRVL Celestial right now, and from Marvell earnings, Celestial AI revenue projections were $500m 2028, $1B 2029 (poet ~10% BOM starlight maybe) I don't see $POET as a bottleneck, but high potential architectural enabler.
-
看好AXTI垄断潜力，COHR最安全，AAOI/IQE高弹性，TSEM短期滞涨。
$AXTI 是我的个人最爱，因为其衬底/原料被用于任何光子学瓶颈环节。我只需要有人加入他们的董事会，告诉他们自己是半垄断地位并提价。关于时间框架：$LITE、$COHR、$AAOI 可能在未来两年因需求激增而迎来高光时刻。由于共封装光学(CPO)的影响，可插拔光模块的指数级增长曲线可能在 2028 年略有放缓，因此对类似中际旭创/新易盛的玩家会更谨慎。$AAOI 自产激光器，所以如果有转型时间，我确信他们会通过认证。简而言之：最安全的是 $COHR，他们业务广泛多元化。最高上行空间可能是 $AAOI、$IQE、$AXTI，鉴于其起点较小。Soitec 和 $TSEM 有显著上行空间，两年内可能翻倍或翻三倍。但 2026 年可能是死钱。
英文原文
$AXTI is my personal favorite since inp substrate/feedstock is used across any photonics bottleneck. I just need someone to join their board and tell them that they're a semi-monopoly and to price hike. For timeframes: $LITE, $COHR, $AAOI probably get their time to shine next two years from extreme demand ramp. The exponential curve for pluggables probably dwindles a tiny bit in 2028 from cpo? So would be more cautious with innolight/eoptolink type players. $AAOI manufactures their own lasers, so I'm sure they'll get qualified if there's any time for a pivot. TLDR: For safest, $COHR. They're widely diversified. Highest upside probably $AAOI, $IQE, $AXTI given their small starting point. Significant upside for Soitec, $TSEM could probably double or triple in 2 years. But probably dead capital for 2026.
-
分析IQE、AAOI及AXTI等小众AI供应链标的的早期机会与执行风险。
可能尚未被定价的只有那些更小众的领域，例如在磷化铟(InP)衬底上的外延工艺，或者那些刚刚触及拐点的新型激光器/收发器玩家。 我曾提到 $IQE 处于极早期阶段（但风险更高），因为其同行 Landmark 的估值已达 35-40 亿美元。 这取决于重组情况。 $AAOI 也处于极早期，情况更微妙，因为他们提供端到端服务（激光器 -> 设计 -> 组装）。如果他们能在每一层执行到位，淘汰 $FN/中际旭创 类型的玩家并扩大利润率，可能实现 10 倍增长。 但这很大程度上取决于执行能力。 $AXTI 也许有机会，如果 Shkreli 加入董事会并教他们如何涨价的话。
英文原文
Only ones probably not priced in are the more niche ones like epitaxy process on top of the InP substrates or maybe new laser/transceiver players that hit their inflection point. I mentioned $IQE was extremely early (but more high risk), given their peer Landmark was priced at $3.5-$4B. This depends on restructuring. $AAOI is also very early, it's more nuanced since they do end to end (laser -> design -> assembly). If they can execute across each layer and cut out $FN/Innolight type players and expand margins, could be a 10x. This largely depends on execution though. $AXTI maybe if Shkreli joins their board and teaches them how to hike prices.
-
看好存储板块，NAND涨价超预期，预计跑赢大盘。
@eclement04 不，我在做多存储和波动率上升。Q2 NAND 价格被三星和可能的 SK 海力士翻倍，比分析师预期高出 4-10 倍。宏观背景影响大多数股票，但我预计该板块将方向性跑赢大盘。
英文原文
@eclement04 No I’m long on memory and volatility increases. Q2 NAND prices were doubled by Samsung and likely SK Hynix, around 4-10 times more than analyst expectations. There’s a lot of macro backdrop affecting majority of stocks, but I expect that sector to directionally outperform.
-
IREN因GPU采购及ATM增发稀释，轻资产优势丧失，散户价值或归零。
@Brian_S1_1991 第一次大规模买入 $IREN 是在 20 多美元高位至 30 美元低位区间。随后在上涨途中退出。去年它是一家很有前景的轻资产公司，但今年因购买 GPU 和极端的自动取款机(ATM)增发稀释而艰难转型，这可能会彻底抹去散户股东的价值。 https://t.co/ocQ6vcx1Qz
英文原文
@Brian_S1_1991 First major $IREN buys were in the high $20’s low 30’s. Then exited on the way up. It was very promising, asset light company last year but hard pivoted with GPU buys and extreme ATM dilution that might just wipe out retail share value. https://t.co/ocQ6vcx1Qz
-
IREN投资逻辑已变，警惕巨额ATM融资风险。
我去年曾做多 $IREN，但投资逻辑已发生实质性变化。 再次强调，我现在对 $IREN 没有任何经济利益，但我确实关注散户的最佳利益。 鉴于涉及真金白银，有情绪波动是可以理解的，但如果想继续做多，重要的是要意识到来自 60 亿美元自动取款机(ATM)融资的明显危险信号(red flags)。 人们可以自由决定如何操作自己的投资组合。
英文原文
I was long $IREN last year, but the thesis has materially changed. Again I have zero economic interest in $IREN now but I do look out for retail’s best interest. It’s fine if there’s emotion involved given money is at stake, but it’s important to become aware of the glaring red flags from a $6B ATM if they want to continue going long. People are free to do whatever they want with their own portfolio.
-
质疑BMNR偏离以太坊质押目标，资金投向巧克力公司，建议重新评估。
是的，其他股票如 $BMNR 也是如此。 如果投资者支持的目标是收购 5% 的以太坊($ETH) 供应量，并通过质押(Staking) + 代币升值来实现复利回报。 那么该公司在甚至尚未收购 5% 的以太坊之前，就将 2 亿美元资金转向一家 YouTuber 的巧克力棒公司。 也许是时候重新考虑了。
英文原文
Yes it’s the same with other stocks like $BMNR. If the goal investors supported was to acquire 5% of $ETH supply and compound return through staking + token appreciation. Then the company redirects $200M into a YouTuber’s chocolate bar company before even acquiring 5% of Ethereum. Might be a good time to reconsider.
-
AXTI受铟价新高及光子需求驱动，订单饱满且扩产，未来盈利将体现涨价。
铟非标准件(Indium nonstandard)价格已创历史新高。 当人们审视 $AXTI 的财报时，常犯的一个错误是用短缺/光子学(Photonics)需求爆发前约1年前的合同来评判其业绩。 我预计随着新合同周期到来 -> 半年后的前瞻盈利将开始体现大量涨价影响。 但财报显示他们订单已排满且正在扩产（这是利好）。
英文原文
7n indium nonstandard is up to all time highs. When people look at $AXTI earnings, they often make the mistake of judging contracts from maybe 1Y ago before a lot of the shortages/photonics demand began. I'd expect when new contract cycles hit -> forward earnings a half a year from now will start showing in a lot of the price hikes. But earnings showed they were already fully backlogged and are expanding capacity (which is positive).
-
解析做空MSTR实为套利mnav溢价回归，非方向性做空且风险有限。
我认为情况比这稍显微妙。做空 $MSTR 的人同时也做多比特币，他们是在对 mnav（市值与净资产价值）溢价进行套利，使其从 1.8-2 倍的水平回归至 1 倍。他们并非方向性做空，且亏损通常有限，因为很难看到 MicroStrategy 的 mnav 涨至 2 倍或 4 倍。
英文原文
I think it's slightly more nuanced than this. People who are short $MSTR are also long Bitcoin and are arbitrating the mnav premium from 1.8-2 levels back to 1. They're not directionally short and losses are usually caped since hard to see mnav increasing to 2 or 4 for microstrategy.
-
提及ATOM本月巧合上涨80%。
@JorgeA76608 $ATOM 巧合的是，本月上涨了 80%。https://t.co/3ZF4d4DsLt
英文原文
@JorgeA76608 $ATOM coincidentally is up 80% this month. https://t.co/3ZF4d4DsLt
-
诉讼撤销与营收加速超预期，HIMS 周一走势值得关注。
@himshouse 确实如此，没人预料到诉讼被撤销和营收重新加速会同时发生。这就是为什么 $HIMS 流通盘的 40% 以上被做空。真正的惊喜总是有创造历史的潜力，我们周一见分晓。
英文原文
@himshouse It's true though, don't think anyone expected both the lawsuit to be dropped and revenue to re-accelerate at the same time. Hence why 40%+ of $HIMS float was sold short. Genuine surprises like always have the potential to make history, we'll see what happens on Monday.
-
存储涨价背景下，SK海力士回调是极佳买点。
@PronologieFR 三星前几天刚刚将NAND闪存价格翻倍，DRAM内存价格也上涨了。在我看来，SK海力士($SKHYNIX)在回调时看起来是一个极好的买入机会。市场对石油/液化天然气(LNG)进口的担忧被夸大了。
英文原文
@PronologieFR Samsung just doubled NAND prices the other day, DRAM prices hiked. imo SK Hynix looks like a terrific buy on the dip. Fears are overblown on oil/LNG imports.
-
打包购买多家金融科技龙头公司的成本约等于 Stripe。
@101010_jv Ayden - $330亿 $PYPL - $430亿 $HOOD - $690亿 $CRCL - $230亿 33+43+69+23。你实际上可以用和 Stripe 差不多的价格，把金融科技(Fintech)领域的所有领军企业打包买下来。
英文原文
@101010_jv Ayden - $33B $PYPL - $43B $HOOD - $69B $CRCL - $23B 33+43+69+23. You can literally put together all the leaders in Fintech for around the same price as Stripe.
-
RVI 开盘大跌，批评其持仓为高位套现提供流动性。
$RVI 现已上市，开盘下跌 16%。 很遗憾地说，如果你以 1590 亿美元的估值买入 Stripe 等公司，只是为了让员工和管理层套现； 同时以 750 亿美元的估值买入 Revolt，在其估值刚刚大幅飙升之后； 而与此同时，从 Ayden 到 $HOOD 等公开市场上的金融科技股正在暴跌。 你就是退出流动性（exit liquidity）。
英文原文
$RVI is now live and is down 16% on market open. Sorry to say, but if you’re buying companies like Stripe @ $159B valuations to cash out employees and executives. While buying Revolt @ $75B, after freshly jacked up valuations. All while fintechs in public markets from Ayden to $HOOD are tanking in public markets. You’re exit liquidity.
-
对比ENPH高SI增长与GME历史暴涨，探讨HIMS走势。
@EikonDD 是的，目前看来可能性很大。人们曾讨论过 $ENPH 在 14% 的销售收入(SI) 下翻倍，但现在是 40%+。 记得 $GME 那一年从 $3 涨到 $150 真的令人难忘。不认为我们会再看到那样的重演，但好奇 $HIMS 会走向何方。
英文原文
@EikonDD Yeah seems pretty likely at this point. People were talking about $ENPH doubling off 14% SI but this is 40%+ Was really memorable seeing $GME go from $3->$150 that one year. Don’t think we’ll ever see a repeat of that but curious where $HIMS heads.
-
HIMS遭空头猛烈做空，跌幅剧烈但反弹潜力同样巨大。
@yianisz 我最近几个月一直在看空头将 $HIMS 砸得粉碎。惊讶于他们竟能找到足够的股票借入并做空流通盘的 40%。虽然跌幅剧烈，但反之亦然（即空头回补也会引发剧烈反弹）。
英文原文
@yianisz I was just watching short sellers nuke $HIMS into the ground past few months. Was surprised they managed find enough shares to borrow and short 40% of the float. The drop was violent but it works in reverse too.
-
IREN稀释源于对冲套利非做空，HIMS方向性做空易引发轧空。
@BlackPantherCap $IREN 的 60 亿美元稀释来自自动取款机(ATM)增发和可转换票据对冲套利，并非真正的做空。$HIMS 主要是方向性做空，而上述情况实际上会引发空头挤压(Short Squeeze)。
英文原文
@BlackPantherCap $IREN is $6B dilution from an ATM and convertible note arbitrage from hedging, not actual shorts. $HIMS was primarily directional shorts, and these scenarios actually lead a short squeeze
-
HIMS利空出尽基本面反转，周一或现历史性空头挤压，作者计划买入。
周一可能创造历史。 因为历史上最大规模的空头挤压之一可能正在上演。 > 机构做空了 $HIMS 40% 的流通股（规模极大） > 预期其营收增长为 0 > 押注 FDA 和 $NVO 会让该公司破产 然而，所有转折都在一天内发生： > $HIMS 与 Novo Nordisk 的诉讼被撤销。 > Hims 营收突然再次加速。 > 与此同时，$HIMS 通过 Eucalyptus 扩展至加拿大、澳大利亚和日本。 > $HIMS 通过 Zava 扩展至英国和欧洲。 > 现在突然拥有了合法的全球分销网络、健康的资产负债表、与 $NVO 的合作关系，以及 40% 的流通股被做空。 可能没人预料到这一点。 尤其是那些认为 HIMS 会破产、现在面临数十亿美元无限亏损的空头。 我也曾看空 $HIMS，但这确实是一个巨大的反转故事。 两种可能的场景： 1. 如果所有空头周一同时平仓，可能会发生类似大众汽车式的空头挤压。 很可能一些空头为了风险管理想在其他人之前以 $22 的价格退出，这将引发即时的买盘压力。 2. 另一种场景是随着 $NVO 合作关系的建立，$HIMS 的增长重新点燃，并随着公司基本面改善，出现类似 $TSLA 式的缓慢挤压。 鉴于 $HIMS 曾交易于 $70，现在回到 $22，且兼具法律清晰度和营收加速。 我个人会在周一跳上这艘船，添柴加火，看看事态如何发展。 这可能是历史的缔造时刻。
英文原文
Monday could make history. As one of the largest short squeezes in history could unfold. > Institutions shorted 40% of $HIMS (extraordinarily large) > expecting 0 revenue growth > betting the FDA and $NVO would bankrupt the company All in one day: > $HIMS lawsuit with Novo Nordisk dropped. > Hims sudden revenue acceleration begins again. > All while $HIMS expanded to Canada, Australia, and Japan via Eucalyptus in the meantime. > $HIMS expanded to UK and Europe with Zava > Now suddenly a legal global distribution network, healthy balance sheet, $NVO partnership, and 40% of the float shorted. Likely 0 people expected this. Especially short sellers who now face billions in infinite losses, that thought HIMS would be bankrupted. I was bearish on $HIMS too, but this is a massive turnaround story. The two likely scenarios: 1. One scenario is a Volkswagen-type short squeeze on Monday if all the short sellers tries to cover at once Monday It's very likely some short sellers want to exit before others do at $22 for risk-management and this causes immediate buying pressure. 2. The other scenario is growth in $HIMS reignited with the $NVO partnership and a slower $TSLA-style squeeze over time as company fundamentals improve. Given $HIMS was once trading at $70 and now it's back at $22, with both legal clarity + revenue acceleration. I would personally hop on the boat on Monday to add fuel to the fire to see where this heads. Could be history in the making.
-
IREN巨额ATM构成抛压，建议持有其他数据中心股。
@Agrippa_Inv 我们看看这对 $IREN 意味着什么。为持有者加油，但结构性上，60亿美元的定向增发(ATM)在任何反弹中都会对他们不利。这就是为什么持有其他没有如此巨大抛压和可能面临市值一半卖压的数据中心(DC)股票可能更好。
英文原文
@Agrippa_Inv We'll see how this bodes for $IREN. Cheering on the holders, but structurally the $6B ATM works against them in any rally. Which is why it's probably better to hold other DC stocks that don't have that large overhang and likely selling pressure of half the MC.
-
HIMS周一轧空或载入史册，空头措手不及
@tweet_tj 如果所有空头同时平仓，那场面将会相当滑稽。 $HIMS 周一的轧空(short squeeze)事件可能会载入史册，因为我认为所有人都措手不及，且最大流通盘(max float)已被做空。
英文原文
@tweet_tj It’s going to be pretty funny if all the shorts cover at the same time. $HIMS short squeeze Monday could genuinely be one for the history books since I think literally everyone was caught off guard + max float was shorted
-
HIMS 股价暴跌后现 22 美元吸引力，或成做多良机。
是的，即使在此之后，$HIMS 仍然下跌了超过 44%。市场此前已计入诉讼和收入损失的影响，但这一消息彻底颠覆了局面。根据新闻后续发展，这可能再次成为一个不错的做多机会。考虑到在风波爆发前股价交易区间为 50-60 美元，22 美元看起来是一个相当有吸引力的入场点。
英文原文
Yeah even after this $HIMS is still down way over 44%+. Markets were pricing in a lawsuit + revenue loss but this news just flipped everything on its head. Might be a good long again depending on how the news unfolds. But $22 looks like a pretty attractive entry point given they were trading in the $50s-$60s before all the drama began
-
HIMS与NVO合作消息令市场及空头意外
@pepemoonboy 我相当确定 $HIMS 的消息让所有人都措手不及，尤其是所有的空头。完全没想到 $HIMS 会和 $NVO 达成合作，这真是出乎意料。
英文原文
@pepemoonboy Pretty sure the $HIMS news caught everyone off guard, especially all the short sellers. Did not expect a $HIMS partnership with $NVO out of all things.
-
HIMS监管风险解除且高做空比例，股价具备反弹潜力。
@demarscrypto 很多人在 $HIMS 50-70 美元时买入，因此即使现在股价为 22 美元，随着监管问题得到解决，看起来又具备了吸引力。此外，目前流通盘中有 40% 被做空，这为股价反弹增添了燃料。
英文原文
@demarscrypto Lot of people bought $HIMS, 50-$70, so even at $22 with the regulatory issues cleared up, looks good again. And now there’s 40% of the float shorted to add fuel to the fire
-
$HIMS 与 $NVO 和解合作，盘后大涨 37% 或引发逼空。
恭喜 $HIMS 的持有者，盘后股价回升 37%。 看来 $NVO 撤回了诉讼，并与 $HIMS 合作销售 NOVO 品牌的 GLP-1（胰高血糖素样肽-1）药物。 鉴于 $HIMS 曾交易于 70 美元，且一度成为被做空最多的股票之一。 看到因利好消息引发的逼空行情（Short Squeeze）我并不感到惊讶。
英文原文
Congrats to the $HIMS holders, stock back up 37% after hours. It looks like $NVO dropped the lawsuit and partnered with $HIMS to sell NOVO branded GLP-1s. Given HIMS was once trading at $70 and became one of the most shorted stocks. Would not be surprised to see a short squeeze off the positive news.
-
看好LITE和COHR，受NVDA注资及Google资本支出扩张驱动。
它们现在的定价非常合理，我预计像 $LITE 这样的公司明年股价可能会达到 1000 美元以上。它们每家都刚刚从 $NVDA 获得了 20 亿美元的新增注资，且估值远高于当前股价，同时现在正获得数十亿美元的标普指数被动资金流入。因此，除了今天 AH 对 MM 的压制/小动作外，这在结构上为光子学(Photonics)板块带来了巨大的顺风。如果查看 Google TPU 的物料清单(BOM)，$LITE 约占 8-12%，而 Google 仅在今年的资本支出(capex)就大幅扩张（例如约 1800 亿美元）。我很确定这两家公司的 2028 年远期市盈率(fwd p/e)都在 20 年代中期或 30 年代初期，考虑到它们的增长（$COHR 业务全面，$LITE 在光电路交换(OCS)领域具有垄断地位），这是合理的。
英文原文
They're really well priced right now, and I expect companies like $LITE to probably end up $1000+ next year. Each of them just got $2B each in new funding from $NVDA at way higher share values and now have billions in S&P index passive inflows. So this is structurally a large tailwind for the photonics sector, minus AH MM pinning/shenanigans today. If you look at Google TPU BOM $LITE is ~8-12% of it and Google's expanding capex enormously this year alone (eg. ~$180B). Pretty sure both of them have 2028 mid ~20s or low 30s fwd p/e, which makes sense given their growth ( $COHR does everything, $LITE OCS monopoly).
-
认为$COHR已计入标普500资金流入，入场可能偏晚。
@Sam_Badawi 我觉得你可能已经错过 $COHR 的入场时机了。那根巨大的 0.076% 的K线可能已经计入了标普500指数新增的数十亿美元流入资金。
英文原文
@Sam_Badawi Think you might be late to $COHR. That large .076% candle might have already priced in the few billion of new inflow from the S&P 500.
-
COHR和LITE因纳入标普500指数，盘后大幅反弹。
市场对两家领先的光子学(Photonics)公司发布的突发新闻感到兴奋。 由于它们现在被纳入标普500指数(S&P 500)： $COHR 受此消息影响大幅上涨 .047%。 此前该股今日曾下跌 7.12%。 $LITE 受此消息影响上涨 1.27%。 此前该股今日曾下跌 14.19%。 这真是一次抛物线式的盘后反弹。
英文原文
Markets are excited about breaking news from the two leading photonics companies. As they are now included in the S&P 500: $COHR is up massive .047% on the news. This follows a 7.12% drop today. $LITE is up 1.27% on the news. This follows a 14.19% drop today. This is truly a parabolic after-hours rally.